ISHF President Maresz Speaks at Global Supplement Conference, Emphasizes Significance of Global K2 Deficiency
Dr. Katarzyna Maresz, president of the International Science and Health Foundation, speaks at the first Vitamin K2 Workshop at SupplySide West 2015. Educating suppliers and manufacturers about the widespread Vitamin K deficiency, particularly in child populations, and the difference Vitamin K2 can make towards improved bone and cardiovascular health.
Dr. Katarzyna Maresz, president of the International Science and Health Foundation, was honored to participate in the SupplySide West Global Conference and Expo, the largest tradeshow for the dietary supplement, food and pharmaceutical industries in the United States. Organized by Informa to take place October 7-9, 2015 in Las Vegas, NV, the show’s agenda included a first-ever “Vitamin K2 Workshop: New Findings & Trends for Heart and Bone Health.”
Dr. Maresz was joined by renowned researchers and practitioners, and addressed the following topics:
- Latest developments with Vitamin K2 and heart health; the flaws in the conventional approach to healthcare, such as statin use inhibiting K2 synthesis; and how Vitamin K2 is being incorporated into integrative medicine.
- New findings showing the role Vitamin K2 plays in energy production, muscle health, and nerve health (i.e., neuropathy).
- An examination of the research that has been conducted and that is underway showing Vitamin K2 as menaquinone-7 (MK-7) to be a novel and effective treatment for cardiovascular disease.
- Body of evidence pointing to a global deficiency in Vitamin K2, particularly in child populations, and the difference Vitamin K2 can make towards improved bone and cardiovascular health.
“Studies support the statistic that 97% of the population is K deficient, and children showed the largest tissue-specific vitamin deficiency,” said Dr. Maresz in her presentation. “Young bones are highly active – in fact, chidren’s osteocalcin levels are 8-10 times higher compared to adults. Thus, their vitamin K requirement is also higher.
“This can be addressed,” she continued. “A randomized, placebo-controlled, double-blind study showed that just 45 mcg of Vitamin K2 as MK-7 daily could positively effect the activation of bone-building proteins in children. Further, Vitamin K2 as MK-7 is safe regarding increased thrombosis risk.”
For more information regarding SupplySide West or the Vitamin K2 Workshop, visit http://west.supplysideshow.com/.